Effect of simvastatin on hemostasis in patients with isolated hypertriglyceridemia

Robert Krysiak1, Boguslaw Okopien

  • 1Department of Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.

Pharmacology
|October 2, 2013
PubMed

Insights

Simvastatin treatment positively impacts blood clotting and clot breakdown in patients with high triglycerides. This statin therapy may offer benefits for individuals with elevated triglyceride levels and associated cardiovascular risks.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pharmacology

Background:

  • Elevated triglyceride levels are linked to early-onset and accelerated coronary artery disease.
  • Hypertriglyceridemia is a significant risk factor for cardiovascular complications.

Purpose of the Study:

  • To investigate the effects of simvastatin on coagulation and fibrinolysis in patients with isolated hypertriglyceridemia.
  • To assess simvastatin's impact on hemostatic variables in this patient population.

Main Methods:

  • A 90-day randomized controlled trial involving 39 patients with hypertriglyceridemia and peripheral artery sclerosis.
  • Patients received either 40 mg daily simvastatin or a placebo.
  • Assessed plasma lipids, glucose homeostasis, and hemostatic variables at baseline and post-treatment.

Main Results:

  • Simvastatin significantly reduced plasma levels/activity of fibrinogen, factor VII, and plasminogen activator inhibitor-1.
  • No significant reduction in von Willebrand factor levels was observed with simvastatin.
  • Simvastatin tended to prolong prothrombin and partial thromboplastin times, indicating altered coagulation dynamics.

Conclusions:

  • Statin treatment, specifically simvastatin, exerts a multifaceted influence on coagulation and fibrinolysis.
  • These findings suggest potential cardiovascular benefits of simvastatin in patients with isolated hypertriglyceridemia.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...